{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T18:16:47Z","timestamp":1743013007311,"version":"3.40.3"},"publisher-location":"Tokyo","reference-count":50,"publisher":"Springer Japan","isbn-type":[{"type":"print","value":"9784431568452"},{"type":"electronic","value":"9784431568476"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-4-431-56847-6_13","type":"book-chapter","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T15:24:09Z","timestamp":1543332249000},"page":"243-253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Current Cell-Based Therapies in the Chronic Liver Diseases"],"prefix":"10.1007","author":[{"given":"Taketo","family":"Nishina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko Tomita","family":"Hoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,28]]},"reference":[{"issue":"7","key":"13_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00535-016-1216-y","volume":"51","author":"H Fukui","year":"2016","unstructured":"Fukui H, Saito H, Ueno Y, Uto H, Obara K, Sakaida I et al (2016) Evidence-based clinical practice guidelines for liver cirrhosis 2015. J Gastroenterol 51(7):629\u2013650","journal-title":"J Gastroenterol"},{"key":"13_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev-med-052915-015720","volume":"68","author":"S Naggie","year":"2017","unstructured":"Naggie S, Muir AJ (2017) Oral combination therapies for hepatitis C virus infection: successes, challenges, and unmet needs. Annu Rev Med 68:345\u2013358","journal-title":"Annu Rev Med"},{"issue":"2","key":"13_CR3","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jhep.2011.06.022","volume":"56","author":"SJ Forbes","year":"2012","unstructured":"Forbes SJ, Newsome PN (2012) New horizons for stem cell therapy in liver disease. J Hepatol 56(2):496\u2013499","journal-title":"J Hepatol"},{"issue":"2","key":"13_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00535-016-1258-1","volume":"52","author":"S Terai","year":"2017","unstructured":"Terai S, Tsuchiya A (2017) Status of and candidates for cell therapy in liver cirrhosis: overcoming the \u201cpoint of no return\u201d in advanced liver cirrhosis. J Gastroenterol 52(2):129\u2013140","journal-title":"J Gastroenterol"},{"issue":"2","key":"13_CR5","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/hep.29514","volume":"67","author":"Rohit Loomba","year":"2017","unstructured":"Loomba R, Lawitz E, Mantry PS, Jayakumar S, Caldwell SH, Arnold H et al (2018) The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: a randomized, phase 2 trial. Hepatology 67(2):549\u2013559","journal-title":"Hepatology"},{"issue":"6793","key":"13_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/35018642","volume":"406","author":"MR Alison","year":"2000","unstructured":"Alison MR, Poulsom R, Jeffery R, Dhillon AP, Quaglia A, Jacob J et\u00a0al (2000) Hepatocytes from non-hepatic adult stem cells. Nature 406(6793):257","journal-title":"Nature"},{"issue":"10","key":"13_CR7","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/MEG.0b013e3283488b00","volume":"23","author":"ME Amer","year":"2011","unstructured":"Amer ME, El-Sayed SZ, El-Kheir WA, Gabr H, Gomaa AA, El-Noomani N et al (2011) Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells. Eur J Gastroenterol Hepatol 23(10):936\u2013941","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"13_CR8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/ctr.12179","volume":"27","author":"MA Amin","year":"2013","unstructured":"Amin MA, Sabry D, Rashed LA, Aref WM, el-Ghobary MA, Farhan MS et al (2013) Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study. Clin Transpl 27(4):607\u2013612","journal-title":"Clin Transpl"},{"issue":"12","key":"13_CR9","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.dld.2015.08.018","volume":"47","author":"P Andreone","year":"2015","unstructured":"Andreone P, Catani L, Margini C, Brodosi L, Lorenzini S, Sollazzo D et al (2015) Reinfusion of highly purified CD133+ bone marrow-derived stem\/progenitor cells in patients with end-stage liver disease: a phase I clinical trial. Dig Liver Dis 47(12):1059\u20131066","journal-title":"Dig Liver Dis"},{"issue":"12","key":"13_CR10","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1136\/gutjnl-2014-308410","volume":"64","author":"L Dubuquoy","year":"2015","unstructured":"Dubuquoy L, Louvet A, Lassailly G, Truant S, Boleslawski E, Artru F et al (2015) Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis. Gut 64(12):1949\u20131960","journal-title":"Gut"},{"issue":"3","key":"13_CR11","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1007\/s12015-011-9322-y","volume":"8","author":"M El-Ansary","year":"2012","unstructured":"El-Ansary M, Abdel-Aziz I, Mogawer S, Abdel-Hamid S, Hammam O, Teaema S et al (2012) Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis. Stem Cell Rev 8(3):972\u2013981","journal-title":"Stem Cell Rev"},{"issue":"10","key":"13_CR12","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1097\/MEG.0b013e32832a1f6c","volume":"21","author":"P Kharaziha","year":"2009","unstructured":"Kharaziha P, Hellstrom PM, Noorinayer B, Farzaneh F, Aghajani K, Jafari F et al (2009) Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol 21(10):1199\u20131205","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"13_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1053\/j.gastro.2017.03.022","volume":"153","author":"A King","year":"2017","unstructured":"King A, Houlihan DD, Kavanagh D, Haldar D, Luu N, Owen A et al (2017) Sphingosine-1-phosphate prevents egress of hematopoietic stem cells from liver to reduce fibrosis. Gastroenterology 153(1):233\u2013248 e16","journal-title":"Gastroenterology"},{"issue":"24","key":"13_CR14","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.3748\/wjg.v13.i24.3359","volume":"13","author":"M Mohamadnejad","year":"2007","unstructured":"Mohamadnejad M, Namiri M, Bagheri M, Hashemi SM, Ghanaati H, Zare Mehrjardi N et al (2007) Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol 13(24):3359\u20133363","journal-title":"World J Gastroenterol"},{"issue":"3","key":"13_CR15","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/hep.24434","volume":"54","author":"L Peng","year":"2011","unstructured":"Peng L, Xie DY, Lin BL, Liu J, Zhu HP, Xie C et al (2011) Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. Hepatology 54(3):820\u2013828","journal-title":"Hepatology"},{"issue":"6","key":"13_CR16","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1002\/hep.20452","volume":"40","author":"I Sakaida","year":"2004","unstructured":"Sakaida I, Terai S, Yamamoto N, Aoyama K, Ishikawa T, Nishina H et al (2004) Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology 40(6):1304\u20131311","journal-title":"Hepatology"},{"issue":"3","key":"13_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/scrt459","volume":"5","author":"H Salama","year":"2014","unstructured":"Salama H, Zekri AR, Medhat E, Al Alim SA, Ahmed OS, Bahnassy AA et al (2014) Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease. Stem Cell Res Ther 5(3):70","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"13_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/hep.23354","volume":"51","author":"K Si-Tayeb","year":"2010","unstructured":"Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, Duris C et al (2010) Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 51(1):297\u2013305","journal-title":"Hepatology"},{"issue":"8","key":"13_CR19","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1097\/TP.0000000000001773","volume":"101","author":"EM Sokal","year":"2017","unstructured":"Sokal EM, Lombard CA, Roelants V, Najimi M, Varma S, Sargiacomo C et al (2017) Biodistribution of liver-derived mesenchymal stem cells after peripheral injection in a hemophilia a patient. Transplantation 101(8):1845\u20131851","journal-title":"Transplantation"},{"issue":"1","key":"13_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053719","volume":"8","author":"L Spahr","year":"2013","unstructured":"Spahr L, Chalandon Y, Terraz S, Kindler V, Rubbia-Brandt L, Frossard JL et al (2013) Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial. PLoS One 8(1):e53719","journal-title":"PLoS One"},{"issue":"6","key":"13_CR21","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1002\/hep.28693","volume":"64","author":"KT Suk","year":"2016","unstructured":"Suk KT, Yoon JH, Kim MY, Kim CW, Kim JK, Park H et al (2016) Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: phase 2 trial. Hepatology 64(6):2185\u20132197","journal-title":"Hepatology"},{"issue":"10","key":"13_CR22","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1634\/stemcells.2005-0542","volume":"24","author":"S Terai","year":"2006","unstructured":"Terai S, Ishikawa T, Omori K, Aoyama K, Marumoto Y, Urata Y et al (2006) Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 24(10):2292\u20132298","journal-title":"Stem Cells"},{"issue":"Suppl 1","key":"13_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/jgh.12029","volume":"28","author":"L Wang","year":"2013","unstructured":"Wang L, Li J, Liu H, Li Y, Fu J, Sun Y et al (2013) Pilot study of umbilical cord-derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis. J Gastroenterol Hepatol 28(Suppl 1):85\u201392","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"13_CR24","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1111\/jgh.12653","volume":"29","author":"L Xu","year":"2014","unstructured":"Xu L, Gong Y, Wang B, Shi K, Hou Y, Wang L et al (2014) Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: regulation of Treg\/Th17 cells. J Gastroenterol Hepatol 29(8):1620\u20131628","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl 2","key":"13_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1440-1746.2011.07024.x","volume":"27","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Lin H, Shi M, Xu R, Fu J, Lv J et\u00a0al (2012) Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J Gastroenterol Hepatol 27(Suppl 2):112\u2013120","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"13_CR26","doi-asserted-by":"publisher","first-page":"725","DOI":"10.5966\/sctm.2012-0034","volume":"1","author":"M Shi","year":"2012","unstructured":"Shi M, Zhang Z, Xu R, Lin H, Fu J, Zou Z et al (2012) Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients. Stem Cells Transl Med 1(10):725\u2013731","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"13_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/liv.12218","volume":"34","author":"YO Jang","year":"2014","unstructured":"Jang YO, Kim YJ, Baik SK, Kim MY, Eom YW, Cho MY et al (2014) Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study. Liver Int 34(1):33\u201341","journal-title":"Liver Int"},{"issue":"1","key":"13_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13287-017-0541-2","volume":"8","author":"N Lanthier","year":"2017","unstructured":"Lanthier N, Lin-Marq N, Rubbia-Brandt L, Clement S, Goossens N, Spahr L (2017) Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns? Stem Cell Res Ther 8(1):88","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"13_CR29","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/apt.12645","volume":"39","author":"JK Moore","year":"2014","unstructured":"Moore JK, Stutchfield BM, Forbes SJ (2014) Systematic review: the effects of autologous stem cell therapy for patients with liver disease. Aliment Pharmacol Ther 39(7):673\u2013685","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"13_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2015.06.007","volume":"17","author":"A Trounson","year":"2015","unstructured":"Trounson A, McDonald C (2015) Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell 17(1):11\u201322","journal-title":"Cell Stem Cell"},{"issue":"9","key":"13_CR31","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1089\/scd.2011.0074","volume":"20","author":"T Saito","year":"2011","unstructured":"Saito T, Okumoto K, Haga H, Nishise Y, Ishii R, Sato C et al (2011) Potential therapeutic application of intravenous autologous bone marrow infusion in patients with alcoholic liver cirrhosis. Stem Cells Dev 20(9):1503\u20131510","journal-title":"Stem Cells Dev"},{"issue":"1","key":"13_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S2468-1253(17)30326-6","volume":"3","author":"PN Newsome","year":"2018","unstructured":"Newsome PN, Fox R, King AL, Barton D, Than NN, Moore J et\u00a0al (2018) Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial. Lancet Gastroenterol Hepatol 3(1):25\u201336","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"13_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S2468-1253(17)30359-X","volume":"3","author":"N Lanthier","year":"2018","unstructured":"Lanthier N (2018) Haemopoietic stem cell therapy in cirrhosis: the end of the story? Lancet Gastroenterol Hepatol. 3(1):3\u20135","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"47","key":"13_CR34","doi-asserted-by":"publisher","first-page":"16772","DOI":"10.1073\/pnas.1413481111","volume":"111","author":"K Takayama","year":"2014","unstructured":"Takayama K, Morisaki Y, Kuno S, Nagamoto Y, Harada K, Furukawa N et al (2014) Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes. Proc Natl Acad Sci USA 111(47):16772\u201316777","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"13_CR35","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1172\/JCI43122","volume":"120","author":"ST Rashid","year":"2010","unstructured":"Rashid ST, Corbineau S, Hannan N, Marciniak SJ, Miranda E, Alexander G et al (2010) Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest 120(9):3127\u20133136","journal-title":"J Clin Invest"},{"issue":"6","key":"13_CR36","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3727\/096368910X508960","volume":"19","author":"M Iwamuro","year":"2010","unstructured":"Iwamuro M, Komaki T, Kubota Y, Seita M, Kawamoto H, Yuasa T et al (2010) Hepatic differentiation of mouse iPS cells in vitro. Cell Transplant 19(6):841\u2013847","journal-title":"Cell Transplant"},{"issue":"6330","key":"13_CR37","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1126\/science.355.6330.1109","volume":"355","author":"D Normile","year":"2017","unstructured":"Normile D (2017) iPS cell therapy reported safe. Science 355(6330):1109\u20131110","journal-title":"Science"},{"issue":"19","key":"13_CR38","doi-asserted-by":"publisher","first-page":"8639","DOI":"10.1073\/pnas.0911647107","volume":"107","author":"Y Kuroda","year":"2010","unstructured":"Kuroda Y, Kitada M, Wakao S, Nishikawa K, Tanimura Y, Makinoshima H et al (2010) Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci USA 107(19):8639\u20138643","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"13_CR39","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/nprot.2013.076","volume":"8","author":"Y Kuroda","year":"2013","unstructured":"Kuroda Y, Wakao S, Kitada M, Murakami T, Nojima M, Dezawa M (2013) Isolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells. Nat Protoc 8(7):1391\u20131415","journal-title":"Nat Protoc"},{"issue":"5","key":"13_CR40","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3727\/096368916X693662","volume":"26","author":"M Iseki","year":"2017","unstructured":"Iseki M, Kushida Y, Wakao S, Akimoto T, Mizuma M, Motoi F et al (2017) Muse cells, nontumorigenic pluripotent-like stem cells, have liver regeneration capacity through specific homing and cell replacement in a mouse model of liver fibrosis. Cell Transplant 26(5):821\u2013840","journal-title":"Cell Transplant"},{"issue":"7","key":"13_CR41","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1089\/scd.2013.0473","volume":"23","author":"F Ogura","year":"2014","unstructured":"Ogura F, Wakao S, Kuroda Y, Tsuchiyama K, Bagheri M, Heneidi S et al (2014) Human adipose tissue possesses a unique population of pluripotent stem cells with nontumorigenic and low telomerase activities: potential implications in regenerative medicine. Stem Cells Dev 23(7):717\u2013728","journal-title":"Stem Cells Dev"},{"issue":"24","key":"13_CR42","doi-asserted-by":"publisher","first-page":"9875","DOI":"10.1073\/pnas.1100816108","volume":"108","author":"S Wakao","year":"2011","unstructured":"Wakao S, Kitada M, Kuroda Y, Shigemoto T, Matsuse D, Akashi H et al (2011) Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts. Proc Natl Acad Sci USA 108(24):9875\u20139880","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"13_CR43","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3727\/096368916X690881","volume":"25","author":"M Dezawa","year":"2016","unstructured":"Dezawa M (2016) Muse cells provide the pluripotency of mesenchymal stem cells: direct contribution of Muse cells to tissue regeneration. Cell Transplant 25(5):849\u2013861","journal-title":"Cell Transplant"},{"issue":"2","key":"13_CR44","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1253\/circj.CJ-17-0552","volume":"82","author":"T Tanaka","year":"2018","unstructured":"Tanaka T, Nishigaki K, Minatoguchi S, Nawa T, Yamada Y, Kanamori H et al (2018) Mobilized Muse cells after acute myocardial infarction predict cardiac function and remodeling in the chronic phase. Circ J 82(2):561\u2013571","journal-title":"Circ J"},{"issue":"10","key":"13_CR45","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1681\/ASN.2016070775","volume":"28","author":"N Uchida","year":"2017","unstructured":"Uchida N, Kushida Y, Kitada M, Wakao S, Kumagai N, Kuroda Y et al (2017) Beneficial effects of systemically administered human Muse cells in adriamycin nephropathy. J Am Soc Nephrol 28(10):2946\u20132960","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"13_CR46","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/stem.2206","volume":"34","author":"H Uchida","year":"2016","unstructured":"Uchida H, Morita T, Niizuma K, Kushida Y, Kuroda Y, Wakao S et al (2016) Transplantation of unique subpopulation of fibroblasts, Muse cells, ameliorates experimental stroke possibly via robust neuronal differentiation. Stem Cells 34(1):160\u2013173","journal-title":"Stem Cells"},{"issue":"2","key":"13_CR47","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/ajt.13537","volume":"16","author":"H Katagiri","year":"2016","unstructured":"Katagiri H, Kushida Y, Nojima M, Kuroda Y, Wakao S, Ishida K et al (2016) A distinct subpopulation of bone marrow mesenchymal stem cells, Muse cells, directly commit to the replacement of liver components. Am J Transplant 16(2):468\u2013483","journal-title":"Am J Transplant"},{"issue":"3","key":"13_CR48","doi-asserted-by":"publisher","first-page":"e0116009","DOI":"10.1371\/journal.pone.0116009","volume":"10","author":"T Yamauchi","year":"2015","unstructured":"Yamauchi T, Kuroda Y, Morita T, Shichinohe H, Houkin K, Dezawa M et al (2015) Therapeutic effects of human multilineage-differentiating stress enduring (MUSE) cell transplantation into infarct brain of mice. PLoS One 10(3):e0116009","journal-title":"PLoS One"},{"issue":"2","key":"13_CR49","doi-asserted-by":"publisher","first-page":"146","DOI":"10.5966\/sctm.2014-0181","volume":"4","author":"K Kinoshita","year":"2015","unstructured":"Kinoshita K, Kuno S, Ishimine H, Aoi N, Mineda K, Kato H et al (2015) Therapeutic potential of adipose-derived SSEA-3-positive Muse cells for treating diabetic skin ulcers. Stem Cells Transl Med 4(2):146\u2013155","journal-title":"Stem Cells Transl Med"},{"key":"13_CR50","unstructured":"Life Science Institute, Inc., Press release \n                  http:\/\/www.lsii.co.jp\/pdf\/20180115-1.pdf\n                  \n                 (Japanese)"}],"container-title":["Advances in Experimental Medicine and Biology","Muse Cells"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-4-431-56847-6_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T01:07:58Z","timestamp":1561338478000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-4-431-56847-6_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9784431568452","9784431568476"],"references-count":50,"URL":"https:\/\/doi.org\/10.1007\/978-4-431-56847-6_13","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"28 November 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}